BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11853686)

  • 21. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.
    Burnett JR; Wilcox LJ; Huff MW
    Clin Chim Acta; 1999 Aug; 286(1-2):231-42. PubMed ID: 10511295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A two-site model for ApoB degradation in HepG2 cells.
    Wu X; Sakata N; Lele KM; Zhou M; Jiang H; Ginsberg HN
    J Biol Chem; 1997 Apr; 272(17):11575-80. PubMed ID: 9111073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.
    Brown A; Wiggins D; Gibbons GF
    Biochim Biophys Acta; 1999 Sep; 1440(2-3):253-65. PubMed ID: 10521709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2).
    Haghpassand M; Wilder D; Moberly JB
    J Lipid Res; 1996 Jul; 37(7):1468-80. PubMed ID: 8827519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased intracellular degradation and increased secretion of apo B-100 in Hep G2 cells after inhibition of cholesteryl ester synthesis.
    Ooyen C; Zecca A; Zanelli T; Catapano AL
    Atherosclerosis; 1997 Apr; 130(1-2):143-52. PubMed ID: 9126658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
    Bocan TM; Krause BR; Rosebury WS; Mueller SB; Lu X; Dagle C; Major T; Lathia C; Lee H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):70-9. PubMed ID: 10634802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J; Kazemian P; Kulinski A; Rudy D; Aiton A; Thibert RJ; Adeli K
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1035-47. PubMed ID: 11027587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
    Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
    Liao W; Chang BH; Mancini M; Chan L
    J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia.
    Raal FJ; Marais AD; Klepack E; Lovalvo J; McLain R; Heinonen T
    Atherosclerosis; 2003 Dec; 171(2):273-9. PubMed ID: 14644397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assembly and secretion of VLDL in nondifferentiated Caco-2 cells stably transfected with human recombinant ApoB48 cDNA.
    Luchoomun J; Zhou Z; Bakillah A; Jamil H; Hussain MM
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2955-63. PubMed ID: 9409282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.
    Peluso MR; Dixon JL
    Lipids; 1997 Aug; 32(8):811-23. PubMed ID: 9270972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
    Huff MW; Telford DE; Barrett PH; Billheimer JT; Gillies PJ
    Arterioscler Thromb; 1994 Sep; 14(9):1498-508. PubMed ID: 8068612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
    Insull W; Koren M; Davignon J; Sprecher D; Schrott H; Keilson LM; Brown AS; Dujovne CA; Davidson MH; McLain R; Heinonen T
    Atherosclerosis; 2001 Jul; 157(1):137-44. PubMed ID: 11427213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
    Macri J; Adeli K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the endoplasmic reticulum 60 protein ER-60 downregulates apoB100 secretion by inducing its intracellular degradation via a nonproteasomal pathway: evidence for an ER-60-mediated and pCMB-sensitive intracellular degradative pathway.
    Qiu W; Kohen-Avramoglu R; Rashid-Kolvear F; Au CS; Chong TM; Lewis GF; Trinh DK; Austin RC; Urade R; Adeli K
    Biochemistry; 2004 Apr; 43(16):4819-31. PubMed ID: 15096051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane.
    Ingram MF; Shelness GS
    J Lipid Res; 1996 Oct; 37(10):2202-14. PubMed ID: 8906597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsomal triacylglycerol transfer protein prevents presecretory degradation of apolipoprotein B-100. A dithiothreitol-sensitive protease is involved.
    Benoist F; Nicodeme E; Grand-Perret T
    Eur J Biochem; 1996 Sep; 240(3):713-20. PubMed ID: 8856075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.